Table 1.
Demographics characteristics and Medication-assisted treatment (MAT) use by age groups
| Age | ||||||
|---|---|---|---|---|---|---|
| 18–29 n = 22,270 |
30–39 n = 24,314 |
40–49 n = 17,819 |
50–59 n = 19,184 |
60–64 n = 5050 |
Total n = 88,637 |
|
| Race n (%) | ||||||
| Non-Hispanic White | 16,327 (73.3) |
15,697*** (64.6) |
6237*** (35.0) |
4001*** (20.9) |
1019*** (20.2) |
43,281 (48.8) |
| Non-Hispanic Black | 1577 (7.1) |
1951*** (8.02) |
3074*** (17.3) |
5475*** (28.5) |
1696*** (33.6) |
13,773 (15.5) |
| Latinx | 1688 (7.6) |
3792*** (15.6) |
5830*** (32.7) |
6926*** (36.1) |
1674*** (33.2) |
19,910 (22.5) |
| Other | 1282 (5.8) |
1894*** (7.8) |
2107*** (11.8) |
2366*** (12.3) |
586*** (11.6) |
8235 (9.3) |
| Unknown | 1396 (6.3) |
980*** (4.0) |
571*** (3.2) |
416*** (2.2) |
75*** (1.5) |
3438 (3.9) |
| Gender n (%) | ||||||
| Female | 8874 (39.9) |
9429* (38.8) |
5766*** (32.4) |
6199*** (32.3) |
1611*** (31.9) |
31,879 (36.0) |
| Male | 13,396 (60.2) |
14,885** (61.2) |
12,053*** (67.6) |
12,985*** (67.7) |
3439*** (68.1) |
56,758 (64.0) |
| Location n (%) | ||||||
| New York City (NYC) | 4502 (20.2) |
7428*** (30.6) |
10,562*** (59.3) |
14,385*** (35.0) |
4023*** (80.0) |
40,900 (46.1) |
| Outside NYC | 17,768 (79.8) |
16,886*** (69.5) |
7257*** (40.7) |
4799*** (25.0) |
1027*** (20.3) |
47,737 (53.9) |
| Mean Medicaid eligibility months, (standard deviation) | 10.6 (2.5) |
10.9*** (2.3) |
11.1*** (2.1) |
11.4*** (1.8) |
11.5*** (1.6) |
11.0 (2.2) |
| Treatment Utilization n (%) | ||||||
| Medication-Assisted Treatment (MAT) | 10,948 (49.2) |
15,172*** (62.4) |
12,181*** (68.4) |
14,363*** (74.9) |
4262*** (84.4) |
56,926 (64.2) |
| -Methadone | 3950 (17.7) |
7209*** (29.7) |
8554*** (48.0) |
12,034*** (62.7) |
3868*** (76.6) |
35,615 (40.2) |
| -Naltrexone | 656 (3.0) |
584*** (2.4) |
374*** (2.1) |
278*** (1.5) |
37*** (0.7) |
1929 (2.2) |
| -Buprenorphine | 6342 (28.5) |
7379*** (30.4) |
3253*** (18.3) |
2051*** (10.7) |
357*** (7.1) |
19,382 (21.9) |
| Non-Medication Treatment | 11,322 (50.8) |
9142*** (37.6) |
5638*** (31.6) |
4821*** (25.1) |
788*** (15.6) |
31,711 (35.8) |
*P-value calculated from two sample z-test and t-test to compare patients in each age group with 18–29 year olds. *p < 0.05, **p < 0.01, ***p < 0.001